Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
1 |
Alakurtti K et al. |
Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
|
2 |
Autio A et al. |
Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation.
|
3 |
Brück A et al. |
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.
|
4 |
Edison P et al. |
Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
|
5 |
Eerola K et al. |
Lentivirus mediated alpha-melanocyte stimulating hormone overexpression in the hypothalamus decreases diet induced obesity in mice.
|
6 |
Ellfolk U et al. |
Brain volumetric correlates of memory in early Parkinson's disease.
|
7 |
Garibotto V et al. |
Cholinergic activity correlates with reserve proxies in Alzheimer's disease.
|
8 |
Ghimire LV et al. |
Variation in the alpha2A adrenoceptor gene and the effect of dexmedetomidine on plasma insulin and glucose.
|
9 |
Grönroos P, Koskinen P. |
Kliinisten laboratoriotutkimusten luotettavuus.
|
10 |
Hagelberg NM et al. |
Ticlopidine inhibits both O-demethylation and renal clearance of tramadol, increasing the exposure to it, but itraconazole has no marked effect on the ticlopidine-tramadol interaction.
|
11 |
Heinonen I et al. |
Inhibition of alpha-adrenergic tone disturbs the distribution of blood flow in the exercising human limb.
|
12 |
Hoppu U et al. |
Diet and blood lipids in 1-4 year-old children.
|
13 |
Huupponen R. |
Lääkkeen annos, pitoisuus ja vaste.
|
14 |
Huupponen R. |
Ruoansulatuskanavan lääkkeet.
|
15 |
Huupponen R, Raunio H. |
Farmakokinetiikka.
|
16 |
Huupponen R, Raunio H. |
Vierasainemetabolia.
|
17 |
Huupponen R, Rouru J. |
Diabeteslääkkeet.
|
18 |
Huupponen R, Viikari J. |
Statins and the risk of developing diabetes.
|
19 |
Jahnukainen K et al. |
Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation.
|
20 |
Jokinen P et al. |
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
|
21 |
Joutsa J et al. |
Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.
|
22 |
Kalliola S et al. |
Maternal smoking affects lung function and airway inflammation in young children with multiple-trigger wheeze.
|
23 |
Kemppainen NM et al. |
Five-year follow-up of (11)C-PIB uptake in Alzheimer's disease and MCI.
|
24 |
Kivimäki M et al. |
Influence of retirement on nonadherence to medication for hypertension and diabetes.
|
25 |
Koskimies P et al. |
Oral bioavailability of ospemifene improves with food intake.
|
26 |
Koskimies P et al. |
Single-dose and steady-state pharmacokinetics of ospemifene, a selective estrogen receptor modulator, in postmenopausal women.
|
27 |
Lampela P et al. |
Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study.
|
28 |
Lampela P et al. |
Comprehensive geriatric assessment decreases prevalence of orthostatic hypotension in older persons.
|
29 |
Laurén HB et al. |
Status epilepticus alters neurogenesis and decreases the number of GABAergic neurons in the septal dentate gyrus of 9-day-old rats at the early phase of epileptogenesis.
|
30 |
Lehmusvuori A et al. |
Homogeneous duplex polymerase chain reaction assay using switchable lanthanide fluorescence probes.
|
31 |
Lehtinen T et al. |
Effects of cytochrome P450 inhibitors and inducers on the metabolism and pharmacokinetics of ospemifene.
|
32 |
Leinonen V et al. |
Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.
|
33 |
Linna M et al. |
Circulating oxidised LDL lipids, when proportioned to HDL-c, emerged as a risk factor of all-cause mortality in a population-based survival study.
|
34 |
Meyer C et al. |
The MLL recombinome of acute leukemias in 2013.
|
35 |
Mosconi L et al. |
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
|
36 |
Nordberg A et al. |
A European multicentre PETstudy of fibrillar amyloid in Alzheimer's disease.
|
37 |
Nuutila J et al. |
A rapid flow cytometric method for distinguishing between febrile bacterial and viral infections.
|
38 |
Nuutila J et al. |
Use of complement regulators, CD35, CD46, CD55, and CD59 on leukocytes as markers for diagnosis of viral and bacterial infections .
|
39 |
Pemovska T et al. |
Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
|
40 |
Posti JP et al. |
A polymorphism in the protein kinase C gene PRKCB is associated with alpha2-adrenoceptor-mediated vasoconstriction.
|
41 |
Rikala M et al. |
Channelling of statin use towards low-risk population and patients with diabetes.
|
42 |
Rinne P et al. |
Genetic and pharmacological mouse models of chronic melanocortin activation show enhanced baroreflex control of heart rate.
|
43 |
Rinne P et al. |
Alpha-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction.
|
44 |
Rinne P et al. |
Alpha-MSH analogue attenuates blood pressure elevation in DOCA-salt hypertensive mice.
|
45 |
Rokka J et al. |
19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical.
|
46 |
Saarikoski T et al. |
Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
|
47 |
Salomäki H et al. |
Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood.
|
48 |
Silvennoinen R et al. |
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
|
49 |
Snellman A et al. |
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
|
50 |
Stenholm T et al. |
High-throughput screening of colonization samples for methicillin-resistant Staphylococcus aureus .
|
51 |
Tertti K et al. |
Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin.
|
52 |
Tirkkonen T et al. |
Epidemiology of CYP3A4-mediated clopidogrel drug-drug interactions and their clinical consequences.
|
53 |
Turpeinen M et al. |
Effects of ospemifene on drug metabolism mediated by cytochrome P450 enzymes in humans in vitro and in vivo.
|
54 |
Upmeier E et al. |
Statin use among older Finns stratified according to cardiovascular risk.
|
55 |
Uusitalo-Seppälä R et al. |
Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.
|
56 |
Vainionpää MH et al. |
Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine.
|
57 |
Virta JJ et al. |
Midlife sleep characteristics associated with late life cognitive function.
|
58 |
Virta JJ et al. |
Midlife cardiovascular risk factors and late cognitive impairment.
|
59 |
Voipio-Pulkki L-M et al. |
Lääkehuolto ja palvelurakenneuudistus.
|